Vascular access for optimal hematopoietic stem cell collection
Chloé Couzin(Délégation Paris 5), Marianne Delville(Délégation Paris 5), Emilie Dupont(Assistance Publique – Hôpitaux de Paris), Felipe Suárez(Hôpital Necker-Enfants Malades), Alessandra Magnani(Inserm), Sandra Manceau(Assistance Publique – Hôpitaux de Paris), Jean‐Herlé Raphalen(Université Sorbonne Paris Nord), Jean‐Sébastien Diana(Délégation Paris 5), Ambroise Marçais(Hôpital Necker-Enfants Malades), Horiya Amrane(Assistance Publique – Hôpitaux de Paris), David Sibon(Hôpital Necker-Enfants Malades), François Lefrère(Hôpital Necker-Enfants Malades), Elisa Magrin(Inserm), Laure Joseph(Inserm), Marina Cavazzana(Université Rennes 2)
Cited by 12
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k